Mehul V Raval1, Xue Wang2, Marleta Reynolds3, Anne C Fischer4. 1. Division of Research and Optimal Patient Care, American College of Surgeons, Chicago, IL 60611, USA; Division of Pediatric Surgery, Department of Surgery, Feinberg School of Medicine, Northwestern University, Children's Memorial Hospital, Chicago, IL 60614, USA. Electronic address: m-raval@md.northwestern.edu. 2. Division of Research and Optimal Patient Care, American College of Surgeons, Chicago, IL 60611, USA. 3. Division of Pediatric Surgery, Department of Surgery, Feinberg School of Medicine, Northwestern University, Children's Memorial Hospital, Chicago, IL 60614, USA. 4. Division of Pediatric Surgery, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Abstract
BACKGROUND: Congenital diaphragmatic hernia (CDH) is the costliest noncardiac congenital defect. Extracorporeal membrane oxygenation (ECMO) is a treatment strategy offered to those babies with CDH who would not otherwise survive on conventional therapy. The primary objective of our study was to identify the leading source of expenditures in CDH care. METHODS: All patients surviving CDH repair were identified in the Kids' Inpatient Database (KID) from 1997 to 2006, with costs converted to 2006 US dollars. Patients were categorized into groups based on severity of disease for comparison including CDH repair only, prolonged ventilator dependence, and ECMO use. Factors associated with greater expenditures in CDH management were analyzed using a regression model. RESULTS: Eight hundred thirty-nine patients from 213 hospitals were studied. Extracorporeal membrane oxygenation use decreased from 18.2% in 1997 to 11.4% in 2006 (P = .002). Congenital diaphragmatic hernia survivors managed with ECMO cost more than 2.4 times as much as CDH survivors requiring only prolonged ventilation postrepair and 3.5 times as much as those with CDH repair only (both P < .001). Age, multiplicity of diagnoses, patient transfer, inhaled nitric oxide use, prolonged ventilation, and ECMO use were all associated with higher costs. Extracorporeal membrane oxygenation use was the single most important factor associated with higher costs, increasing expenditures 2.4-fold (95% confidence interval, 2.1-2.8). Though the CDH repair with ECMO group constituted 12.2% of patients, this group has the highest median costs ($156,499.90/patient) and constitutes 28.5% of national costs based on CDH survivors in the KID. Annual national cost for CDH survivors is $158 million based on the KID, and projected burden for all CDH patients exceeds $250 million/year. CONCLUSIONS: Extracorporeal membrane oxygenation use is the largest contributing factor to the economic burden in CDH. With limited health care resources, judicious resource utilization in CDH care merits further study.
BACKGROUND:Congenital diaphragmatic hernia (CDH) is the costliest noncardiac congenital defect. Extracorporeal membrane oxygenation (ECMO) is a treatment strategy offered to those babies with CDH who would not otherwise survive on conventional therapy. The primary objective of our study was to identify the leading source of expenditures in CDH care. METHODS: All patients surviving CDH repair were identified in the Kids' Inpatient Database (KID) from 1997 to 2006, with costs converted to 2006 US dollars. Patients were categorized into groups based on severity of disease for comparison including CDH repair only, prolonged ventilator dependence, and ECMO use. Factors associated with greater expenditures in CDH management were analyzed using a regression model. RESULTS: Eight hundred thirty-nine patients from 213 hospitals were studied. Extracorporeal membrane oxygenation use decreased from 18.2% in 1997 to 11.4% in 2006 (P = .002). Congenital diaphragmatic hernia survivors managed with ECMO cost more than 2.4 times as much as CDH survivors requiring only prolonged ventilation postrepair and 3.5 times as much as those with CDH repair only (both P < .001). Age, multiplicity of diagnoses, patient transfer, inhaled nitric oxide use, prolonged ventilation, and ECMO use were all associated with higher costs. Extracorporeal membrane oxygenation use was the single most important factor associated with higher costs, increasing expenditures 2.4-fold (95% confidence interval, 2.1-2.8). Though the CDH repair with ECMO group constituted 12.2% of patients, this group has the highest median costs ($156,499.90/patient) and constitutes 28.5% of national costs based on CDH survivors in the KID. Annual national cost for CDH survivors is $158 million based on the KID, and projected burden for all CDH patients exceeds $250 million/year. CONCLUSIONS: Extracorporeal membrane oxygenation use is the largest contributing factor to the economic burden in CDH. With limited health care resources, judicious resource utilization in CDH care merits further study.
Authors: Lan Yu; Ashley D Sawle; Julia Wynn; Gudrun Aspelund; Charles J Stolar; Marc S Arkovitz; Douglas Potoka; Kenneth S Azarow; George B Mychaliska; Yufeng Shen; Wendy K Chung Journal: Hum Mol Genet Date: 2015-06-01 Impact factor: 6.150
Authors: Duy T Dao; Lorenzo Anez-Bustillos; Amy Pan; Alison A O'Loughlin; Paul D Mitchell; Gillian L Fell; Meredith A Baker; Bennet S Cho; Prathima Nandivada; Arthur P Nedder; Charles J Smithers; Nancy Chen; Robert Comeau; Kevin Holmes; Susan Kalled; Angela Norton; Bohong Zhang; Mark Puder Journal: Surgery Date: 2018-09-05 Impact factor: 3.982
Authors: Ryan P Cauley; Kristina Potanos; Nora Fullington; Sigrid Bairdain; Catherine A Sheils; Jonathan A Finkelstein; Dionne A Graham; Jay M Wilson Journal: J Pediatr Surg Date: 2014-12-17 Impact factor: 2.545
Authors: Augusto Zani; Wendy K Chung; Jan Deprest; Matthew T Harting; Tim Jancelewicz; Shaun M Kunisaki; Neil Patel; Lina Antounians; Pramod S Puligandla; Richard Keijzer Journal: Nat Rev Dis Primers Date: 2022-06-01 Impact factor: 52.329
Authors: Elizabeth M Sefton; Mirialys Gallardo; Claire E Tobin; Brittany C Collins; Mary P Colasanto; Allyson J Merrell; Gabrielle Kardon Journal: Elife Date: 2022-09-26 Impact factor: 8.713
Authors: Ryan P Cauley; Alexander Stoffan; Kristina Potanos; Nora Fullington; Dionne A Graham; Jonathan A Finkelstein; Heung Bae Kim; Jay M Wilson Journal: J Pediatr Surg Date: 2013-06 Impact factor: 2.545
Authors: Nathaly M Sweeney; Shareef A Nahas; Shimul Chowdhury; Miguel Del Campo; Marilyn C Jones; David P Dimmock; Stephen F Kingsmore Journal: Cold Spring Harb Mol Case Stud Date: 2018-06-01